pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
human papillomavirus (virus like particle, 9-valent) vaccine
Gardasil 9
Cervical Intraepithelial Neoplasia (CIN)
$MRKMerck & Co., Inc.
0 catalysts
Marketed
hydralazine
Hydralazine Hydrochloride (hydralazine [INN])
Idiopathic (Essential) Hypertension
Teva Pharmaceuticals USA Inc
0 catalysts
Marketed
hydrochlorothiazide
Hydrochlorothiazide (hydrochlorothiazide [INN])
Edema
Ipca Pharmaceuticals Inc
0 catalysts
← prev
page 184 of 231
next →
131
Pain89
Neurology1
Phase 1
hydrocodone IR
hydrocodone [INN]
Opium (Opioid) Addiction
Elysium Therapeutics Inc
0 catalysts
Marketed
hydrocortisone butyrate
Locoid (hydrocortisone butyrate)
Atopic Dermatitis (Atopic Eczema)
Bausch Health Americas Inc
0 catalysts
Marketed
hydrocortisone valerate
Hydrocortisone Valerate (hydrocortisone valerate)
Atopic Dermatitis (Atopic Eczema)
Cosette Pharmaceuticals Inc
0 catalysts
Marketed
hydroflumethiazide
Saluron (hydroflumethiazide [INN])
Edema
Shire Pharmaceuticals Inc
0 catalysts
Marketed
hydrogen peroxide
hydrogen peroxide [USP]
Cervical Cancer
Kortuc Japan LLC
0 catalysts
Marketed
hydroxocobalamin
Cyanokit (hydroxocobalamin)
Poisoning
BTG International Inc
0 catalysts
Marketed
hydroxychloroquine
Hydroxychloroquine Sulfate (hydroxychloroquine [INN])
Malaria
Creekwood Pharmaceutical Inc
0 catalysts
Phase 2
hydroxyprogesterone caproate
Hydroxyprogesterone Caproate (hydroxyprogesterone caproate [INN])
Premature Labor (Tocolysis)
$LPCNLipocine Inc.
0 catalysts
Marketed
hydroxyurea
Xromi (hydroxyurea)
Sickle Cell Disease With Vaso-Occlusive Crisis
Nova Laboratories Ltd
0 catalysts
Phase 2
hymecromone
Primary Sclerosing Cholangitis
Halo Biosciences Inc
0 catalysts
Marketed
hymenoptera venom allergen extract
White Faced Hornet Hymenoptera Venom Multidose
Allergies
Jubilant HollisterStier LLC
0 catalysts
Marketed
hyoscine methobromide
Methscopolamine Bromide (hyoscine methobromide [INN])
Peptic Ulcers
AACE Pharmaceuticals Inc
0 catalysts
Phase 3
hypericin sodium
Cutaneous T-Cell Lymphoma
$SNGXSOLIGENIX, INC.
0 catalysts
Preclinical
iDose Next Generation
Glaucoma
$GKOSGLAUKOS Corp
0 catalysts
Preclinical
iTOL-102
Type 1 Diabetes (Juvenile Diabetes)
iTolerance Inc
0 catalysts
Preclinical
iVIEW-1701
Ocular Inflammation
iView Therapeutics Inc
0 catalysts
Preclinical
iXB-322
Coronavirus Disease 2019 (COVID-19)
iX Biopharma Ltd
0 catalysts
Phase 2
iadademstat
iadademstat [INN]
Small-Cell Lung Cancer
Oryzon Genomics SA
0 catalysts
Phase 3
ianalumab
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
Tumor necrosis factor receptor superfamily member 13C
$NVSNOVARTIS AG
0 catalysts
Marketed
ibalizumab
Trogarzo (ibalizumab-uiyk)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Theratechnologies Inc
0 catalysts
Phase 2
ibcasertib
ibcasertib [INN]
Breast Cancer
Shenzhen Chipscreen Biosciences Co Ltd
0 catalysts
Phase 2
ibezapolstat
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
$ACXPAcurx Pharmaceuticals, Inc.
0 catalysts
Phase 3
ibramvibart
ibramvibart [INN]
Coronavirus Disease 2019 (COVID-19)
$IVVDInvivyd, Inc.
0 catalysts
Phase 3
ibrilatazar
ibrilatazar [INN]
Metastatic Pancreatic Cancer
Ability Pharmaceuticals SL
0 catalysts
Marketed
ibritumomab tiuxetan
Zevalin (ibritumomab tiuxetan)
B-Cell Non-Hodgkin Lymphoma
Acrotech Biopharma Inc
0 catalysts
Marketed
ibrutinib
Imbruvica (ibrutinib)
Follicular Lymphoma
Tyrosine-protein kinase BTK
$ABBVAbbVie Inc.
0 catalysts
Phase 3
ibudilast
ibudilast [INN]
Amyotrophic Lateral Sclerosis
$MNOVMEDICINOVA INC
0 catalysts